PCR vs antibody, FDA approved, CE marked? The landscape of COVID-19 testing explained
The World Health Organisation has made it very clear that, in order to stop the spread of COVID-19, we need to “find, test, isolate and care for” those confirmed infection cases and also put the close contacts of those confirmed cases into quarantine for the 14-day incubation period of the virus. However, most countries still do not have the COVID-19 testing capacity required to implement these guidelines. Importantly, even though many countries are now recovering from the infection peak, the latest studies point out that we may experience recurrent wintertime outbreaks of COVID-19 after this pandemic wave (depending on the duration of immunity to the virus). The recommendation is that SARS-CoV-2 surveillance should be maintained until as late as 2024.
There has been a lot of confusion around COVID-19 testing and the landscape is evolving very fast. In this article, we want to make this information accessible to everyone. There are broadly two main types of COVID-19 tests:
Another important aspect of this complex landscape is the regulatory status of a specific test. Regulation for in vitro diagnosis (IVD) can be quite difficult to navigate. Given the current situation of public health emergency, several countries are fast-tracking the approval of many IVD tests for COVID-19 testing.
For example, in the US the FDA is issuing Emergency Use Authorizations (EUA) for coronavirus-related medical devices (although is it important to mention that this is not equivalent to an FDA-cleared or FDA-approved device, since it is a temporary authorisation based on the current circumstances). FDA EUA requires, among other things, that the tests have been properly validated according to different criteria (including limit of detection, inclusivity, cross-reactivity and performance in clinical specimens). In the UK and the European Economic Area (EEA), IVD kits generally need to be CE marked (to indicate conformity with health, safety and environmental protection standards) and require approval by the relevant regulatory authorities (for instance, the MHRA in the UK).
Learn about where the Chronomics COVID-19 saliva testing kit sits in this evolving landscape here.
Dr. Daniel E. Martin-Herranz is the CSO and co-founder at Chronomics
Have a podcast? Speak to us about one of our epigenetics experts appearing as a guest.
Coronavirus testing kit
Accurately test for COVID-19 without an invasive swab or medical staff.
Identify risk of chronic illness and measure the success of your treatments using Epigenetics.